CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $266.44M, lower than 95% of all stocks globally
- PositionOperating margin is -78.4%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
266.44MUSDvs all stocks (USD)
Revenue (TTM)
113.02MUSDvs all stocks (USD)
Profit Margin
-66.42%vs Medical Instruments & Supplies peers
Beta
1.00xvs all stocks
52-Week Change
19.08%vs all stocks
Market Capitalization
266.44MUSDvs all stocks (USD)
Enterprise Value
102.14MUSDvs all stocks (USD)
Forward P/E
-7.69xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.36xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.8571xvs Medical Instruments & Supplies peers
Enterprise to Revenue
0.9040xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-1.66xvs Medical Instruments & Supplies peers
Gross Margin
42.27%vs Medical Instruments & Supplies peers
Profit Margin
-66.42%vs Medical Instruments & Supplies peers
Operating Margin
-78.45%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-10.65%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-21.16%vs Medical Instruments & Supplies peers
Revenue (TTM)
113.02MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.57USDUpdated Jul 19, 2026Quarterly Revenue Growth
-6.70%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
47.77MUSDvs all stocks (USD)
EBITDA (TTM)
-61.54MUSDvs all stocks (USD)
Net Income (TTM)
-75.07MUSDvs all stocks (USD)
Operating Cash Flow (TTM)
-43.19MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-8.89MUSDvs all stocks (USD)
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
115.02MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
66.82MUSDFY2025 · Dec 31, 2025Gross Profit
48.20MUSDFY2025 · Dec 31, 2025Operating Income
-68.12MUSDvs all stocks (USD)
Pre-tax Income
-64.59MUSDFY2025 · Dec 31, 2025Income Tax Expense
1.80MUSDFY2025 · Dec 31, 2025Net Income
-68.73MUSDFY2025 · Dec 31, 2025EBIT
-68.12MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-54.31MUSDFY2025 · Dec 31, 2025Research & Development
42.53MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
73.79MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.9400USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.9400USDFY2025 · Dec 31, 2025Basic Shares Outstanding
73.48MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
73.48MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-68.73MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-39.91MUSDFY2025 · Dec 31, 2025Free Cash Flow
-44.11MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
199.28MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-68.73MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
9.97MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
1.85MUSDFY2025 · Dec 31, 2025Stock-based Compensation
10.15MUSDFY2025 · Dec 31, 2025Other Non-cash Items
4.58MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.95MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-1.72MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
2.04MUSDFY2025 · Dec 31, 2025Capital Expenditures
-4.20MUSDFY2025 · Dec 31, 2025Net Acquisitions
-3.61MUSDFY2025 · Dec 31, 2025Purchase of Investments
0.00USDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Other Investing Activity
1.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-6.81MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-61.00KUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-16.88MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-16.94MUSDFY2025 · Dec 31, 2025Shares Outstanding
69.40MSharesUpdated Jul 19, 2026Float Shares
60.74MSharesUpdated Jul 19, 2026Shares Short
2.97MSharesUpdated Jul 19, 2026Short Ratio
3.93daysvs all stocks
Short % of Shares Outstanding
4.54%vs all stocks
% Held by Insiders
6.38%vs all stocks
% Held by Institutions
89.12%vs all stocks
Total Cash (MRQ)
176.96MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.57USDUpdated Jul 19, 2026Total Debt (MRQ)
12.66MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0404xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
5.46xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
4.51USDUpdated Jul 19, 2026Total Assets
403.17MUSDvs all stocks (USD)
Total Current Assets
261.91MUSDFY2025 · Dec 31, 2025Total Liabilities
62.34MUSDFY2025 · Dec 31, 2025Total Non-current Assets
141.26MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
22.55MUSDFY2025 · Dec 31, 2025Total Current Liabilities
39.80MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
199.28MUSDFY2025 · Dec 31, 2025Accounts Receivable
22.20MUSDFY2025 · Dec 31, 2025Inventory
31.06MUSDFY2025 · Dec 31, 2025Accounts Payable
6.52MUSDFY2025 · Dec 31, 2025Short-term Debt
2.23MUSDFY2025 · Dec 31, 2025Deferred Revenue
1.52MUSDFY2025 · Dec 31, 2025Other Current Liabilities
21.18MUSDFY2025 · Dec 31, 2025Long-term Debt
10.97MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
11.58MUSDFY2025 · Dec 31, 2025Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025Retained Earnings
-172.16MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
340.83MUSDvs all stocks (USD)
52-Week Low
2.08USDUpdated Jul 19, 202652-Week High
4.58USDUpdated Jul 19, 202652-Week Change
19.08%vs all stocks
Beta
1.00xvs all stocks
50-Day MA
3.93USDUpdated Jul 19, 2026200-Day MA
3.08USDUpdated Jul 19, 2026Avg 10-Day Volume
374.01KSharesUpdated Jul 19, 2026Avg 30-Day Volume
584.98KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-1.02USDUpdated Jul 19, 2026Other Income / Expense
3.54MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -78.4%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: -0.78Industry median: 0.12Industry P5: -0.16Peers compared: 65.00
Profit margin is -66.4%, lower than 95% of its Medical Instruments & Supplies peers (median 8.2%)Significant
Profit margin: -0.66Industry median: 0.08Industry P5: -0.45Peers compared: 65.00
Price-to-book is 0.86×, lower than 95% of its Medical Instruments & Supplies peers (median 2.65×)Notable
Price-to-book: 0.86Industry median: 2.65Industry P5: 0.93Peers compared: 65.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.42Profit Margin: -0.66
Prioritizing buybacks over growth reinvestmentNotable
Buyback Intensity: 0.06Revenue Growth YoY: -0.07
Financial Health
Altman Z-Score 2.36: grey zoneSignificant
Altman Z-Score: 2.36
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $266.44M, lower than 95% of all stocks globallySignificant
Market cap (USD): 266,443,900Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Applied Energetics Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Piolax Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhongtian Service Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Okabe Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kuzey Boru A.S.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hokko Chemical Industry Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Limak Doğu Anadolu Çimento Sanayi ve Ticaret A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Cica-Huntek Chemical Technology Taiwan Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Kehui Power Automation Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Iochpe-Maxion S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Candel Therapeutics Inc.
1 interpretationCash Elevated Relative to Current Liabilities and Total Assets
Aeva Technologies, Inc.
1 interpretationCash Elevated Relative to Current Liabilities and Total Assets
Immunome Inc.
1 interpretationCash Elevated Relative to Current Liabilities and Total Assets